Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom

BACKGROUND: Treatment paradigms in autoimmune hepatitis (AIH) have remained largely unchanged for decades. Studies report ≤20% of patients have sub‐optimal treatment response with most requiring long‐term therapy. AIM: The United Kingdom Autoimmune Hepatitis (UK‐AIH) study was established to evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dyson, Jessica K., Wong, Lin Lee, Bigirumurame, Theophile, Hirschfield, Gideon M., Kendrick, Stuart, Oo, Ye H., Lohse, Ansgar W, Heneghan, Michael A., Jones, David E. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Care Provision and Outcomes in Autoimmune Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667893/
https://www.ncbi.nlm.nih.gov/pubmed/30226274
http://dx.doi.org/10.1111/apt.14968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667893/
https://www.ncbi.nlm.nih.gov/pubmed/30226274
http://dx.doi.org/10.1111/apt.14968

Ejemplares similares